The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes.
Open accessAbstract
We have developed a functional assay to study the inflammatory capacity of plasma collected from patients with severe gram-negative septic shock. In this assay, elutriation-purified, cryo-preserved human monocytes from one healthy donor are combined with plasma from patients with severe persistent septic shock for 5 h. Subsequently, the plasma is removed, medium added, and procoagulant activity (PCA) and secretion of tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) measured after 18-h incubation. Plasma from 10 patients (6 died) infected with Neisseria meningitidis previously shown to contain high levels of native lipopolysaccharide (LPS) (median 2,700 pg/ml), TNF-alpha, IL-6, IL-8, and complement activation products, had a low net spontaneous inflammatory capacity on the monocytes. The median levels of PCA, TNF-alpha, and IL-6 were 5, 0, and 4%, respectively, of the monocyte activities induced by normal plasma boosted with purified N. meningitidis (Nm)-LPS (2,500 pg/ml; net LPS-boosted capacity, 100%). The levels of PCA, TNF-alpha, and IL-6 obtained with plasma from shock patients were not different from those induced by plasma from 10 meningococcal patients without shock or with plasma from healthy persons. Boosting shock plasma with 2,500 pg/ml Nm-LPS had little effect on the monocyte activities since the median values of PCA, TNF-alpha, and IL-6 revealed a minimal increase from 5, 0, and 4% to 9, 2, and 6%, respectively. The shock plasmas revealed a strong LPS-inhibitory capacity that was largely absent in plasmas from 10 meningococcal patients without shock since the median levels of PCA, TNF-alpha, and IL-6 increased from 5, 0, and 0% to 135, 51, and 73%, respectively, after boosting with 2,500 pg/ml Nm-LPS. The LPS-inhibitory capacity was closely associated with the levels of IL-10. The median levels of IL-10 were 19,000 pg/ml in nine shock patients vs. 22 pg/ml in nine nonshock patients with systemic meningococcal disease. Removal of native IL-10 by immunoprecipitation restored the capacity of plasmas to induce monocyte activation either by native LPS or by boosting with Nm-LPS. IL-4 and TGF-beta were not detected in shock plasmas. In 24 patients with detectable meningococcal LPS ( > 10 pg/ml, 0.1 endotoxin units/ml), the levels of IL-10 were correlated to the levels of LPS (r = 0.79, P < 0.001). IL-10 declined from initiation of antibiotic therapy and paralleled the levels of native LPS. Decreasing levels of IL-10 in serially collected shock plasmas were directly related to increasing monocyte responsiveness after Nm-LPS boosting. These results suggest that IL-10 plays a major role in containing activation of monocytes and possibly other LPS-responsive cells during overwhelming meningococcemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Wurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1025 · Cited by 442
Cited by
Opal, S. M., & DePalo, V. A. (2000) · Chest · doi:10.1378/chest.117.4.1162 · Cited by 1,752
Annane, D., Bellissant, E., & Cavaillon, J.-M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17667-8 · Cited by 1,213
Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a “Sepsis-Like” Syndrome
Adrie, C., Adib-Conquy, M., Laurent, I., Monchi, M., Vinsonneau, C., Fitting, C., Fraisse, F., Dinh-Xuan, A. T., Carli, P., Spaulding, C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000023891.80661.ad · Cited by 1,011
The neutrophil in vascular inflammation
Phillipson, M., & Kubes, P. (2011) · Nature Medicine · doi:10.1038/nm.2514 · Cited by 768
van EEDEN, S. F., TAN, W. C., SUWA, T., MUKAE, H., TERASHIMA, T., FUJII, T., QUI, D., VINCENT, R., & HOGG, J. C. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.5.2010160 · Cited by 698
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.144 · Cited by 588
Self-citationA pilot study of coupled plasma filtration with adsorption in septic shock*
Ronco, C., Brendolan, A., Lonnemann, G., Bellomo, R., Piccinni, P., Digito, A., Dan, M., Irone, M., La Greca, G., Inguaggiato, P., et al. (2002) · Critical Care Medicine · doi:10.1097/00003246-200206000-00015 · Cited by 481
Jin, F.-Y., Nathan, C., Radzioch, D., & Ding, A. (1997) · Cell · doi:10.1016/s0092-8674(00)81880-2 · Cited by 400
Current gaps in sepsis immunology: new opportunities for translational research
Rubio, I., Osuchowski, M. F., Shankar-Hari, M., Skirecki, T., Winkler, M. S., Lachmann, G., La Rosée, P., Monneret, G., Venet, F., Bauer, M., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30567-5 · Cited by 375
Compensatory anti-inflammatory response syndrome
Cavaillon, J.-M., & Adib-Conquy, M. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-07-0421 · Cited by 356
Ronco, C., Tetta, C., Mariano, F., Wratten, M. L., Bonello, M., Bordoni, V., Cardona, X., Inguaggiato, P., Pilotto, L., D’Intini, V., et al. (2003) · Artificial Organs · doi:10.1046/j.1525-1594.2003.07289.x · Cited by 356
Cavaillon, J.-M., Adib-conquy, M., Fitting, C., Adrie, C., & Payen, D. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310015935 · Cited by 336
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation
Shaunak, S., Thomas, S., Gianasi, E., Godwin, A., Jones, E., Teo, I., Mireskandari, K., Luthert, P., Duncan, R., Patterson, S., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt995 · Cited by 331
Cytokine Storm—Definition, Causes, and Implications
Jarczak, D., & Nierhaus, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911740 · Cited by 304
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Lien, E., & Ingalls, R. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201001-00001 · Cited by 273
Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fcγ Receptors
Gerber, J. S., & Mosser, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6861 · Cited by 263
Astiz, M. E., & Rackow, E. C. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01134-9 · Cited by 255
Cao, S., Liu, J., Song, L., & Ma, X. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3484 · Cited by 244
Endotoxemia—menace, marker, or mistake?
Munford, R. S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0316-151r · Cited by 219
“When Brandtzaeg and coworkers [137] exposed naı̈ve human monocytes to patient plasma that contained very large amounts”
BackgroundWang, Y. Y., Dahle, M. K., Ågren, J., Myhre, A. E., Reinholt, F. P., Foster, S. J., Collins, J. L., Thiemermann, C., Aasen, A. O., & Wang, J. E. (2006) · Shock · doi:10.1097/01.shk.0000191377.78144.d9 · Cited by 76
Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis
Adlan, A. M., Panoulas, V. F., Smith, J. P., Fisher, J. P., & Kitas, G. D. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.140861 · Cited by 71
“7) Hypercholesterolemia 16 (14) Antihypertensive agent 47 (42) ACE inhibitor 29 (25.”
Background
Metadata
- Authors
- Brandtzaeg, P., Osnes, L., Ovstebø, R., Joø, G. B., Westvik, A. B., & Kierulf, P.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-07-01
- Volume
- 184
- Issue
- 1
- Pages
- 51-60
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2122036871
- Cited by
- 229
- References
- 2
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.